Eli Lilly: Offers Obesity Meds
Eli Lilly offers obesity medicines to eligible Medicare Part D patients from July 1, 2026, to December 31, 2027, at $50/month
ELI LILLY: MEDICARE GLP-1 BRIDGE PROGRAM LETS ELIGIBLE MEDICARE PART D PATIENTS ACCESS CO'S OBESITY MEDICINES FROM JULY 1, 2026 - DEC 31, 2027 || ESTIMATES ABOUT 20 MLN MEDICARE PATIENTS MAY QUALIFY FOR OBESITY MEDICINE COVERAGE || FOUNDAYO OR ZEPBOUND AVAILABLE TO MEDICARE PART D PATIENTS FOR $50/MONTH STARTING JULY 1